Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypophospholipasemia A2 in systemic sclerosis.

W Pruzanski1, P Lee, E Stefanski

  • 1Inflammation Research Group, University of Toronto, Canada.

The Journal of Rheumatology
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p38 MAPK regulates group IIa phospholipase A2 expression in interleukin-1beta -stimulated rat neonatal cardiomyocytes.

The Journal of biological chemistry·2001
Same author

Mitogenic effect of lipoproteins on human vascular smooth muscle cells: the impact of hydrolysis by gr II A phospholipase A(2).

Laboratory investigation; a journal of technical methods and pathology·2001
Same author

Three Gaucher-disease-producing mutations in a patient with Gaucher disease: mechanism and diagnostic implications.

Acta haematologica·2001
Same author

Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins.

Journal of lipid research·2000
Same author

Cephalic phase of lipolysis is impaired in pancreatic insufficiency: role of gastric lipase.

Scandinavian journal of gastroenterology·2000
Same author

Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin.

Regulatory peptides·1999
Same journal

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

The Journal of rheumatology·2026
Same journal

Concurrent Calcium Pyrophosphate Deposition Disease and Gout of the Cervical Spine Presenting With Subacute Neck Pain and Radiculopathy.

The Journal of rheumatology·2026
Same journal

The Need for Weight Communication Guidelines in Pediatric Rheumatology.

The Journal of rheumatology·2026
Same journal

Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

The Journal of rheumatology·2026
Same journal

Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

The Journal of rheumatology·2026
Same journal

Tumoral Calcinosis-like Calcification of the Proximal Interphalangeal Joint Mimicking Rheumatoid Arthritis Flare.

The Journal of rheumatology·2026
See all related articles

Patients with systemic sclerosis (SSc) show significantly lower serum phospholipase A2 (PLA2) levels compared to healthy individuals. This finding may relate to reduced inflammation in SSc patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Background:

  • Phospholipase A2 (PLA2) plays a role in inflammation and arachidonic acid metabolism.
  • Altered PLA2 activity has been implicated in various autoimmune and inflammatory conditions.

Purpose of the Study:

  • To investigate serum levels of total and pancreatic phospholipase A2 (PLA2) in patients with systemic sclerosis (SSc).
  • To compare PLA2 levels in SSc patients with healthy controls and other autoimmune diseases.
  • To explore the correlation between low PLA2 levels and clinical/laboratory features in SSc.

Main Methods:

  • Quantification of total and pancreatic PLA2 in 91 sera from SSc patients and controls.
  • Comparison of PLA2 levels between SSc patients, healthy adults, and patients with rheumatoid arthritis, systemic lupus erythematosus, or vasculitis.

Related Experiment Videos

  • Analysis of clinical and laboratory parameters in SSc patients stratified by PLA2 levels.

    • Main Results:

    • Mean total PLA2 was significantly lower in SSc patients (216 U/ml) than in controls (317 U/ml) (p < 0.001).
    • 60% of SSc patients had PLA2 levels more than 1 SD below the normal mean.
    • Low serum PLA2 was more prevalent in SSc than in other autoimmune diseases and was associated with lower erythrocyte sedimentation rates and neutrophil/monocyte counts.

    Conclusions:

    • Systemic sclerosis is characterized by significantly reduced serum PLA2 activity.
    • Low PLA2 levels in SSc may contribute to the observed paucity of inflammatory changes.
    • These findings add to the understanding of arachidonic acid pathway dysregulation in SSc.